Prelude Therapeutics Alternatives & Competitors
12 companies similar to Prelude Therapeutics — Precision Oncology, Redefined.
Companies similar to Prelude Therapeutics
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
iOmx Therapeutics AG
Developing next-generation targeted cancer immunotherapy treatments
Germany
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Rival Readout
Competing with Prelude Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
United Kingdom
Artios
Taking control of the DNA Damage Response (DDR)
Cambridge, United Kingdom
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Oxford, United Kingdom
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
About Prelude Therapeutics
Prelude Therapeutics, founded in 2016, is a United States-based clinical-stage precision oncology company redefining cancer treatment with a focus on developing innovative drug candidates that target critical cancer cell pathways. The company uniquely positions itself within the Biopharma, Biotechnology, Health and Wel...
Development of precision oncology medicines, Innovative cancer drug discovery, Targeted protein degradation technology, Pipeline of clinical and preclinical programs
Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Partners
Precision Oncology, Clinical-stage, Cancer Therapeutics, Small Molecule Compounds, Targeted Cancer Pathways, SMARCA2 Degrader, CDK9 Inhibitor, CDK4/6 Inhibitor, Cancer Resistance Mechanisms, Oncology Drug Development, Orally Bioavailable Therapies, Novel Cancer Therapies, Healthcare Innovation, Cancer Research
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Prelude Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Prelude Therapeutics on 27 Nov 2025. The 12 companies listed here were last checked between 28 Jan 2026 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
